XTNT - Xtant Medical Highlights Growing Product Portfolio at NASS 2023 | Benzinga
BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products at the North American Spine Society (NASS) 2023 Annual Meeting, which will be held October 18-21 at the Los Angeles Convention Center in Los Angeles, CA.
"In recent years, we have dramatically expanded our product portfolio, most notably with the introductions of the highly popular OsteoFactor and OsteoVive Plus products and the newly added Coflex and CoFix products," said Sean Browne, Chief Executive Officer of ...